Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Feb 20, 2021 8:06pm
151 Views
Post# 32620152

RE:Some questions for MM

RE:Some questions for MM

DoM

Not a CFA. Know a little bit about accounting thru my brother and what I can pick up from AcoountPrince. He's the man. 

i can't answer most of your questions ... as I'm not an insider and have no knowledge of their future plans ...I can only make edumacated guesses. 

and everything I say is AiMHO


Spectral's ( pleasant) dilemma is in how to monetize Dialco. The fact they have separated it out so clearly so far ( website, etc) suggests an outright sale. The main assets? The IP and the NA rights. The personnel is largely irrelevant although Dr. G is likely key. 

An IPO would allow for a $ raise, to pretend to build a Sales force. Sale of the main assets via sale of the IPO'd co is one way to go. It would reward all Spectral shareholders who would get shares in Dialco to sell at some point in the future. Some may decide to hold, others might sell. There may be other ways to go. Example RTO  

If the Dialco assets are potentially worth 1/2 B or more I would prefer a spun out public co to an asset sale out of Spectral. If the latter, how do you reward the spectral shareholders?  With a taxable cash dividend? 


just some random musings. The good news is that there are two distinct and major assets to monetize. 


MM 

<< Previous
Bullboard Posts
Next >>